© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Adenosine, with the molecular formula C10H13N5O4, belongs to the group of purine nucleosides and features prominently in biochemical processes as a building block of nucleic acids. Created through chemical synthesis pathways, adenosine offers important advantages for consistency and purity compared with extraction from biological sources. This guarantees a stable, reliable supply for research and industrial applications and opens new possibilities for large-scale production. Synthetic adenosine is identified by the HS Code 2934999090, positioning it within the global trade of organic compounds.
This chemical appears as a white or off-white crystalline solid under standard laboratory conditions. Some batches arrive as fine powder or occasionally as larger flakes, reflecting differences in the isolation or drying process. The substance displays limited solubility in water, forming a transparent solution at elevated temperatures, which matters particularly in biochemical assays and pharmaceutical manufacturing. The solid form can range in texture, sometimes with pearl-like granules, but it consistently handles best in a dry, free-flowing state to prevent degradation. Adenosine’s density sits near 1.65 g/cm³, reflecting its relatively high molecular weight compared with many other small biomolecules.
The structure of adenosine includes an adenine base attached to a ribose sugar through a β-N9-glycosidic bond. This arrangement gives rise to distinct physical and chemical properties, such as its melting point near 234°C (with decomposition), and its stability under typical storage conditions, provided it is shielded from excess moisture and heat. Its chemical reactivity relates largely to the purine ring and ribose moieties, where phosphorylation or acylation can yield various biologically active derivatives. These features make it a unique and versatile material for synthetic and biological studies, not only in bench research but also for industrial enzyme reactions and diagnostic formulations.
Labs and production teams often look at purity percentages (commonly >99% HPLC), appearance, identity confirmation by NMR and MS, and specific impurity profiles. Adenosine in crystal or powder form must meet stringent standards for endotoxin levels, microbial contamination, and residual solvents, especially if destined for pharmaceutical use. Specifications also address solubility, particle size, and moisture content, all parameters with direct impact on downstream processing or reactivity in synthesis pipelines. Density, melting point, and refractive index are further physical markers used to profile batches and verify quality at every stage, from raw materials to finished product.
Synthetic adenosine enables researchers and manufacturers to create materials with reproducible properties, vital in fields as diverse as drug discovery, cell culture, and food analysis. Its use in raw form provides a foundation for ATP production in biochemical assays or as a precursor for other purine derivatives. Pharmaceutical development regularly turns to chemically synthesized adenosine for creating intravenous solutions used during heart surgery—not to mention the broad spectrum of research requiring stable, high-purity compounds. By focusing on the material’s physical properties, scientists and industry professionals have more control over formulation, efficacy, and batch-to-batch consistency, underscoring the molecule’s central role in both benchwork and industry alike.
Handling adenosine safely means respecting its classification as a non-hazardous raw material under most conditions, while also following standard laboratory hygiene and storage practices. Direct exposure, inhalation, or ingestion should be avoided even with low-to-moderate hazard classification, as purity levels and trace impurities can introduce variable risks. Those who work with powdered or flaked adenosine wear gloves, use fume extraction if handling in bulk, and rely on sealed containers to limit dust formation and moisture uptake. Regulatory filings reference the HS Code and detailed specifications, with the pharmaceutical grade requiring thorough documentation of every material property and synthesis input. Everyone in the supply chain, from raw material providers to formulation chemists, covers the safety data sheet details and stays alert to potential changes in regulatory status, particularly as new research or clinical findings appear.
One pressing issue for adenosine manufacturers is the reliable sourcing of starting materials and consistent quality control in synthesis. Minor shifts in purity or production conditions can affect the final product’s performance in critical applications like research reagents or therapeutic solutions. Solutions to these challenges come from investing in more advanced purification and analysis techniques—like high-resolution chromatography alongside classic methods, or upgrading facilities with better temperature and humidity controls. In my own work, direct communication with suppliers, close review of batch records, and routine in-house testing have proven essential to minimizing variability and catching issues before they compound. As demand for high-purity biomolecules grows, continued collaboration between industrial chemists, regulatory experts, and academic researchers will shape new production standards and improve overall safety and material performance.
